Divya Paripelli Email & Phone Number

City Of Edinburgh, Scotland, United Kingdom

City Of Edinburgh, Scotland, United Kingdom

Hyderabad, Telangana, India

• Conducted in-depth research into synthetic and semi-synthetic small molecules for their potential use in combating apoptosis-resistant cancer cells, contributing to the development of more effective cancer treatments.
• Led initial screenings to assess the anticancer activity of synthetic and semi-synthetic analogues of compound T, specifically targeting the MIA PaCa-2 cancer cell line known for its resistance to apoptosis.
• Executed a series of experiments to determine the viability of pancreatic cancer cells post-treatment, using standardised assays to quantify therapeutic efficacy and cell survival rates.
• Employed advanced flow cytometry techniques to elucidate the cell cycle effects induced by novel inhibitors, facilitating a deeper understanding of their mechanisms and potential applications in cancer therapy.
• Performed precise Western blot analyses to measure the expression levels of key proteins involved in the apoptosis pathway, such as CDK1, cyclin B1, BAX, Caspase 9, and both pro and active forms of Caspase 3, which are.
• Collaborated with a multidisciplinary team of scientists, researchers, and academic professionals to enhance project outcomes through shared knowledge and integrated research efforts.

Master'S Degree, Medical Biotechnology, First Class

Project: Enumeration and Characterization of Cefotaxime Resistant Coliform ● Isolated anti-microbial resistant bacteria from aquatic.

Master'S Degree, Biotechnology, First Class

Bachelor Of Science - Bsc, Microbiology And Biotechnology